Mass/Heat Transfer Analogy Method in the Research on Convective Fluid Flow through a System of Long Square Mini-Channels

por Wilk, Joanna, Grosicki, Sebastian, Smusz, Robert
Publicado 2022

PB2131: MAGNETISMM-7: AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE 3 STUDY OF ELRANATAMAB VERSUS LENALIDOMIDE IN POST-TRANSPLANT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

por Manteca, Maria Victoria Mateos, Grosicki, Sebastian, Kim, Kihyun, Negre, Eric, Vandendries, Erik
Publicado 2023

Long-Term Safety and Efficacy of Eltrombopag for Advanced Myelodysplastic Syndromes or Acute Myeloid Leukemia and Severe Thrombocytopenia: Results of the ASPIRE Extension Study

por Mittelman, Moshe, Platzbecker, Uwe, Grosicki, Sebastian, Lawniczek, Tomasz, Zhu, Zewen, Selleslag, Dominik
Publicado 2023

PB2130: MAGNETISMM-6: A PHASE 3 STUDY OF ELRANATAMAB + DARATUMUMAB + LENALIDOMIDE VS DARATUMUMAB + LENALIDOMIDE + DEXAMETHASONE IN TRANSPLANT INELIGIBLE PATIENTS WITH NEWLY DIAGNOS...

por Grosicki, Sebastian, Yeh, Su-Peng, Huang, Shang-Yi, Byun, Ja Min, Dirienzo, Christine, Viqueira, Andrea
Publicado 2023

Demyelinating polyneuropathy and lymphoplasmacytic lymphoma coexisting in 36-year-old man: A case report

por Rozłucka, Lesia, Semik-Grabarczyk, Elżbieta, Pietrukaniec, Marta, Żak-Gołąb, Agnieszka, Grabarczyk, Małgorzata, Grosicki, Sebastian, Holecki, Michał
Publicado 2020

Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG study

por van Oers, Marinus, Smolej, Lukas, Petrini, Mario, Offner, Fritz, Grosicki, Sebastian, Levin, Mark-David, Davis, Jaclyn, Banerjee, Hiya, Stefanelli, Tommaso, Hoever, Petra, Geisler, Christian
Publicado 2019

PB2198: TRIAL IN PROGRESS: AN OPEN-LABEL, GLOBAL, MULTICENTER, PHASE 1B/2 STUDY OF TL-895, A BRUTON’S TYROSINE KINASE INHIBITOR (BTKI), ADDED TO RUXOLITINIB (RUX) IN PATIENTS (PTS)...

por Palandri, Francesca, Gröpper, Stefanie, Loschi, Michael, Bellesso, Marcelo, Grosicki, Sebastian, Giraldo, Pilar, Harrison, Claire, Clevenger, Tracy, Stuart, Nikki, Qamoos, Hope, Vosganian, Gregory, Rothbaum, Wayne P., Verstovsek, Srdan, Vachhani, Pankit
Publicado 2023

Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies

por Topp, Max, Dlugosz-Danecka, Monika, Skotnicki, Aleksander B., Salogub, Galina, Viardot, Andreas, Klein, Andreas K., Hess, Georg, Michel, Christian S., Grosicki, Sebastian, Gural, Alex, Schwarz, Sylvia E., Pietzko, Kerstin, Gärtner, Ulrike, Strassz, András, Alland, Leila, Mayer, Jiri
Publicado 2023

Mean Platelet Volume Has Prognostic Value in Chronic Lymphocytic Leukemia

por Masternak, Marta, Puła, Bartosz, Knap, Joanna, Waszczuk-Gajda, Anna, Drozd-Sokołowska, Joanna, Wdowiak, Kamil, Grosicki, Sebastian, Kozłowska, Izabela, Kaźmierczak, Marta, Łabędź, Anna, Szukalski, Łukasz, Wiśniewski, Kamil, Subocz, Edyta, Hałka, Janusz, Szymczyk, Agnieszka, Hus, Marek, Jamroziak, Krzysztof, Giannopoulos, Krzysztof
Publicado 2020

Elotuzumab Plus Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: Final Overall Survival Analysis From the Randomized Phase II ELOQUENT-3 Trial

por Dimopoulos, Meletios A., Dytfeld, Dominik, Grosicki, Sebastian, Moreau, Philippe, Takezako, Naoki, Hori, Mitsuo, Leleu, Xavier, LeBlanc, Richard, Suzuki, Kenshi, Raab, Marc S., Richardson, Paul G., Popa McKiver, Mihaela, Jou, Ying-Ming, Yao, David, Das, Prianka, San-Miguel, Jesús
Publicado 2023

Momelotinib in Myelofibrosis Patients With Thrombocytopenia: Post Hoc Analysis From Three Randomized Phase 3 Trials

por Kiladjian, Jean-Jacques, Vannucchi, Alessandro M., Gerds, Aaron T., Gupta, Vikas, Verstovsek, Srdan, Egyed, Miklos, Platzbecker, Uwe, Mayer, Jiří, Grosicki, Sebastian, Illés, Árpád, Woźny, Tomasz, Oh, Stephen T., McLornan, Donal, Kirgner, Ilya, Yoon, Sung-Soo, Harrison, Claire N., Klencke, Barbara, Huang, Mei, Kawashima, Jun, Mesa, Ruben
Publicado 2023

Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study

por Burger, Jan A., Barr, Paul M., Robak, Tadeusz, Owen, Carolyn, Ghia, Paolo, Tedeschi, Alessandra, Bairey, Osnat, Hillmen, Peter, Coutre, Steven E., Devereux, Stephen, Grosicki, Sebastian, McCarthy, Helen, Simpson, David, Offner, Fritz, Moreno, Carol, Dai, Sandra, Lal, Indu, Dean, James P., Kipps, Thomas J.
Publicado 2019

Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia 

por Barr, Paul M., Owen, Carolyn, Robak, Tadeusz, Tedeschi, Alessandra, Bairey, Osnat, Burger, Jan A., Hillmen, Peter, Coutre, Steve E., Dearden, Claire, Grosicki, Sebastian, McCarthy, Helen, Li, Jian-Yong, Offner, Fritz, Moreno, Carol, Zhou, Cathy, Hsu, Emily, Szoke, Anita, Kipps, Thomas J., Ghia, Paolo
Publicado 2022

P913: LOW-DOSE BELANTAMAB MAFODOTIN (BELAMAF) IN COMBINATION WITH NIROGACESTAT VS BELAMAF MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PHASE 1/2 DREAMM...

por Callander, Natalie, Richardson, Paul, Hus, Marek, Ribrag, Vincent, Martinez-Lopez, Joaquín, Kim, Kihyun, Hoon Lee, Jae, Dimopoulos, Meletios A., Schjesvold, Fredrik, Facon, Thierry, Jo, Jae-Cheol, Min, Chang-Ki, Mielnik, Michał, Cheng, Shinta, Smith, Mary, Breitbach, Caroline J., Brawley, Chris, Sembhi, Harjeet, Lamacchia, John, Grosicki, Sebastian
Publicado 2023

Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2

por Barr, Paul M., Robak, Tadeusz, Owen, Carolyn, Tedeschi, Alessandra, Bairey, Osnat, Bartlett, Nancy L., Burger, Jan A., Hillmen, Peter, Coutre, Steven, Devereux, Stephen, Grosicki, Sebastian, McCarthy, Helen, Li, Jianyong, Simpson, David, Offner, Fritz, Moreno, Carol, Zhou, Cathy, Styles, Lori, James, Danelle, Kipps, Thomas J., Ghia, Paolo
Publicado 2018

Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia: results from the pivotal phase III study COMPLEMENT1

por Tausch, Eugen, Beck, Philipp, Schlenk, Richard F., Jebaraj, Billy M.C., Dolnik, Anna, Yosifov, Deyan Y., Hillmen, Peter, Offner, Fritz, Janssens, Ann, Babu, K. Govind, Grosicki, Sebastian, Mayer, Jiri, Panagiotidis, Panagiotis, McKeown, Astrid, Gupta, Ira V., Skorupa, Alexandra, Pallaud, Celine, Bullinger, Lars, Mertens, Daniel, Döhner, Hartmut, Stilgenbauer, Stephan
Publicado 2020

Tracking Clonal Evolution of Multiple Myeloma Using Targeted Next-Generation DNA Sequencing

por Salomon-Perzyński, Aleksander, Barankiewicz, Joanna, Machnicki, Marcin, Misiewicz-Krzemińska, Irena, Pawlak, Michał, Radomska, Sylwia, Krzywdzińska, Agnieszka, Bluszcz, Aleksandra, Stawiński, Piotr, Rydzanicz, Małgorzata, Jakacka, Natalia, Solarska, Iwona, Borg, Katarzyna, Spyra-Górny, Zofia, Szpila, Tomasz, Puła, Bartosz, Grosicki, Sebastian, Stokłosa, Tomasz, Płoski, Rafał, Lech-Marańda, Ewa, Jakubikova, Jana, Jamroziak, Krzysztof
Publicado 2022

Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT‐2 follow‐up and post‐hoc analyses on progression‐free survival and tumour growth...

por Dimopoulos, Meletios A., Lonial, Sagar, White, Darrell, Moreau, Philippe, Palumbo, Antonio, San‐Miguel, Jesus, Shpilberg, Ofer, Anderson, Kenneth, Grosicki, Sebastian, Spicka, Ivan, Walter‐Croneck, Adam, Magen, Hila, Mateos, Maria‐Victoria, Belch, Andrew, Reece, Donna, Beksac, Meral, Bleickardt, Eric, Poulart, Valerie, Sheng, Jennifer, Sy, Oumar, Katz, Jessica, Singhal, Anil, Richardson, Paul
Publicado 2017

Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial

por Knop, Stefan, Mateos, Maria-Victoria, Dimopoulos, Meletios A., Suzuki, Kenshi, Jakubowiak, Andrzej, Doyen, Chantal, Lucio, Paulo, Nagy, Zsolt, Usenko, Ganna, Pour, Ludek, Cook, Mark, Grosicki, Sebastian, Crepaldi, Andre, Liberati, Anna Marina, Campbell, Philip, Shelekhova, Tatiana, Yoon, Sung-Soo, Losava, Genadi, Fujisaki, Tomoaki, Garg, Mamta, Wang, Jianping, Wroblewski, Susan, Kudva, Anupa, Gries, Katharine S., Fastenau, John, San-Miguel, Jesus, Cavo, Michele
Publicado 2021

Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic...

por Fraser, Graeme A.M., Chanan-Khan, Asher, Demirkan, Fatih, Santucci Silva, Rodrigo, Grosicki, Sebastian, Janssens, Ann, Mayer, Jiri, Bartlett, Nancy L., Dilhuydy, Marie-Sarah, Loscertales, Javier, Avigdor, Abraham, Rule, Simon, Samoilova, Olga, Pavlovsky, Miguel A., Goy, Andre, Mato, Anthony, Hallek, Michael, Salman, Mariya, Tamegnon, Monelle, Sun, Steven, Connor, Anne, Nottage, Kerri, Schuier, Natasha, Balasubramanian, Sriram, Howes, Angela, Cramer, Paula
Publicado 2020